Changes of galectin-3 in CSF and blood have been reported in neurodegenerative diseases including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and PD [12,13,23]. This evidence concerns the gene LGALS3 and Alzheimer disease.